Cancer Stem Cells, Volume 141 in the Advances in Cancer Research series, presents the latest release in this ongoing, well-regarded serial that provides invaluable information on the exciting and fast-moving field of cancer research. Topics covered in this new release include SIX-EYA-DACH network control of cancer stem cell properties, Dormancy and the cancer cell niche, Clonal hematopoiesis: A hematopoietic stem cell disorder of aging, Stringent assays to study human breast cancer stem cells, Regulation of breast cancer stem cell specification and maintenance by hypoxia-inducible factors,…mehr
Cancer Stem Cells, Volume 141 in the Advances in Cancer Research series, presents the latest release in this ongoing, well-regarded serial that provides invaluable information on the exciting and fast-moving field of cancer research. Topics covered in this new release include SIX-EYA-DACH network control of cancer stem cell properties, Dormancy and the cancer cell niche, Clonal hematopoiesis: A hematopoietic stem cell disorder of aging, Stringent assays to study human breast cancer stem cells, Regulation of breast cancer stem cell specification and maintenance by hypoxia-inducible factors, Cancer stem cells in breast and prostate: fact or fiction, and much more.
Curt I. Civin, MD, is the Associate Dean for Research and the Founding Director of the Center for Stem Cell Biology & Regenerative Medicine at the University of Maryland School of Medicine. Prior to joining the University of Maryland, Dr. Civin spent 30 years at Johns Hopkins University School of Medicine leading research and clinical pediatric oncology. In addition to holding 27 biomedical patents, Dr. Civin has received wide recognition for his groundbreaking discovery of the CD34 antigen, and isolation of CD34+ stem cells opened entirely new approaches to leukemia treatment and stem cell transplantation. Dr. Civin has lectured around the world, published more than 250 articles and book chapters, received many awards, and served in leadership positions of multiple distinguished committees and editorial boards.
Tami J. Kingsbury, PhD, is Assistant Professor of Physiology in the Center for Stem Cell Biology & Regenerative Medicine at the University of Maryland School of Medicine. Dr. Kingsbury has extensive background in genetics and molecular biology. She discovered a novel family of calcineurin regulatory factors (RCANs) conserved from yeast to humans, now implicated in diverse human cancers. She helped develop a functional high throughput screen to identify microRNAs capable of regulating leukemia cell growth and differentiation. Her current research is focused on dissecting the role of the PAX-SIX-EYA-DACH (PSEDN) transcriptional network in leukemias. She is a scientific co-founder of 3DBioWorks, whose goal is to develop 3D bioreactors to grow normal and leukemic stem cells. In 2018 she became leader of CRISPR Services within the University of Maryland Cancer Center Translational Shared Services laboratory.
MinJung Kim, PhD, is Research Associate in the Center for Stem Cell Biology & Regenerative Medicine at the University of Maryland School of Medicine. Dr. Kim has broad expertise in cell and molecular biology. Dr. Kim's research focuses on investigating the functional roles of key microRNAs and their target genes in hematopoiesis, especially erythropoiesis, and leukemias.
Inhaltsangabe
1. Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH networkTami J. Kingsbury, MinJung Kim and Curt I. Civin2. Dormancy and cancer stem cells: An enigma for cancer therapeutic targetingSarmistha Talukdar, Praveen Bhoopathi, Luni Emdad, Swadesh Das, Devanand Sarkar and Paul B. Fisher3. Clonal hematopoiesis: Pre-cancer PLUSAlexander J. Silver and Siddhartha Jaiswal4. Assays for functionally defined normal and malignant mammary stem cells Syed M. Musheer Aalam, Philip A. Beer and Nagarajan Kannan5. Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapyLisha Xiang and Gregg L. Semenza6. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment Aksinija A. Kogan, Rena G. Lapidus, Maria R. Baer and Feyruz V. Rassool
1. Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH networkTami J. Kingsbury, MinJung Kim and Curt I. Civin2. Dormancy and cancer stem cells: An enigma for cancer therapeutic targetingSarmistha Talukdar, Praveen Bhoopathi, Luni Emdad, Swadesh Das, Devanand Sarkar and Paul B. Fisher3. Clonal hematopoiesis: Pre-cancer PLUSAlexander J. Silver and Siddhartha Jaiswal4. Assays for functionally defined normal and malignant mammary stem cells Syed M. Musheer Aalam, Philip A. Beer and Nagarajan Kannan5. Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapyLisha Xiang and Gregg L. Semenza6. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment Aksinija A. Kogan, Rena G. Lapidus, Maria R. Baer and Feyruz V. Rassool
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der Steintor 70. V V GmbH (zukünftig firmierend: buecher.de internetstores GmbH)
Geschäftsführung: Monica Sawhney | Roland Kölbl
Sitz der Gesellschaft: Hannover
Amtsgericht Hannover HRB 227001
Steuernummer: 321/neu